ASRS
KPTI icon

Arizona State Retirement System’s Karyopharm Therapeutics KPTI Stock Holding History

Arizona State Retirement System’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,920
Closed -$51.6K – 2181
2023
Q2 		$51.6K Sell
1,920
-153
-7% -$6.59K ﹤0.01% 2170
2023
Q1 		$121K Buy
2,073
+722
+53% +$35.6K ﹤0.01% 2079
2022
Q4 		$68.9K Buy
1,351
+56
+4% +$3.88K ﹤0.01% 2163
2022
Q3 		$106K Buy
1,295
+63
+5% +$4.71K ﹤0.01% 2078
2022
Q2 		$83K Buy
1,232
+7
+0.6% +$642 ﹤0.01% 2150
2022
Q1 		$135K Buy
1,225
+6
+0.5% +$748 ﹤0.01% 2102
2021
Q4 		$118K Buy
1,219
+128
+12% +$12.8K ﹤0.01% 2196
2021
Q3 		$95K Buy
1,091
+9
+0.8% +$934 ﹤0.01% 2175
2021
Q2 		$167K Buy
1,082
+82
+8% +$11.9K ﹤0.01% 2155
2021
Q1 		$158K Buy
1,000
+6
+0.6% +$1.26K ﹤0.01% 2080
2020
Q4 		$231K Sell
994
-36
-3% -$8.34K ﹤0.01% 1873
2020
Q3 		$225K Buy
1,030
+340
+49% +$83.2K ﹤0.01% 1725
2020
Q2 		$196K Sell
690
-96
-12% -$28.4K ﹤0.01% 1661
2020
Q1 		$227K Buy
+786
New +$217K ﹤0.01% 1449

Other funds holding KPTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arizona State Retirement System's KPTI Position: Q3 2023 in Review

Arizona State Retirement System sold out of Karyopharm Therapeutics (KPTI) in Q3 2023, closing a stake of 1,920 shares — an estimated $51.6K sold.

Arizona State Retirement System first reported a position in KPTI in Q1 2020 and held it in 14 quarters. The position peaked at $231K in Q4 2020. 118 funds tracked by Wall St. Rank hold KPTI as of Q3 2023.

  • Arizona State Retirement System reported no remaining Karyopharm Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Arizona State Retirement System sold 1,920 Karyopharm Therapeutics shares in Q3 2023, an estimated $51.6K.
  • Arizona State Retirement System first reported a position in Karyopharm Therapeutics in Q1 2020 and held it in 14 quarters.
  • Arizona State Retirement System's Karyopharm Therapeutics position peaked at $231K in Q4 2020.
  • 118 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2023.

Based on Arizona State Retirement System's 13F filing for Q3 2023, filed 7 Nov 2023.